Jesper Jensen

9PUBLICATIONS
29CO-AUTHORS
Major global burdens of diseasePharmacogenomicsEpidemiological modellingGene and molecular therapyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 09, 2026
Care and Outcomes of New-Onset Heart Failure Across Vulnerable Populations: Temporal Trends in Mortality and Treatment in a Danish Nationwide Cohort From 2003 to 2022.

Sofie-Louise Feentved Ødum, Clara Friis, Caroline Hartwell Garred

|Oct 09, 2025
Trends in Guideline-Directed Medical Therapies and Clinical Management in Patients With Prevalent Versus Incident Heart Failure: A Danish Nationwide Study From 1996 to 2022.

Emma Kidholm Boysen, Lars Køber, Mads Kristian Ersbøll

|Jun 12, 2025
Effects of Empagliflozin on Right Ventricular Function in Heart Failure with Reduced Ejection Fraction.

Massar Omar, Jesper Jensen, Peter H Frederiksen

|Aug 16, 2022
Effect of Empagliflozin on Multiple Biomarkers in Heart Failure: Insights From the Empire Heart Failure Trial.

Jesper Jensen, Massar Omar, Caroline Kistorp

|May 05, 2022
Sodium-glucose co-transporter-2 inhibitors in heart failure with reduced ejection fraction: Current evidence and future perspectives.

Jesper Jensen, Massar Omar, Caroline Kistorp

|Nov 08, 2021
Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial.

Massar Omar, Jesper Jensen, Daniel Burkhoff

Pageof 2

Frequent Collaborators

4 joint publications

Lars Køber

4 joint publications

Morten Schou

3 joint publications

Massar Omar

3 joint publications

Caroline Kistorp